Applying Pharmacogenomics in Drug Therapy of Neurologic and Psychiatric Disorders

Medicine and Dentistry

• Treatment Response 100%
• Drug Therapy 100%
• Neurologic Disease 100%
• Genotype 66%
• Psychoactive Drug 66%
• Mental Disorder 66%
• Nervous System Disorder 66%
• Typical Antipsychotic 33%
• Diseases 33%
• Biological Marker 33%
• Medication Compliance 33%
• Degenerative Disease 33%
• Drug Dose Regimen 33%
• Genetic Variability 33%
• Combination Therapy 33%
• Pathophysiology 33%
• Adverse Drug Reaction 33%
• Epilepsy 33%
• Antidepressant 33%
• Heredity 33%
• Mood Stabilizer 33%
• Optimal Drug Dose 33%
• Drug Response 33%
• Antiparkinson Agent 33%
• Drug 33%
• Chemotherapeutic Agent 33%
• Molecular Diagnostics 33%
• Gene 33%
• Pharmacogenetic Testing 33%
• Therapeutic Procedure 33%
• Comprehension 33%
• Association 33%
• Clinician 33%
• Medication 33%
• Translating (Language) 33%
• Illness 33%
• Cost-Effectiveness Analysis 33%
• Cost Benefit Analysis 33%
• Gene Based Drug 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Neurologic Disease 100%
• Pharmacogenomics 100%
• Pharmaceutical Therapy 100%
• Diseases 66%
• Psychotropic Agent 66%
• Drug 66%
• Biological Marker 33%
• Mood Stabilizer 33%
• Degenerative Disease 33%
• Epilepsy 33%
• Pathophysiology 33%
• Adverse Drug Reaction 33%
• Methimazole 33%
• Antiparkinson Agent 33%